Ian Ford Selected Research

Systolic Heart Failure

12/2019	Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
1/2017	Financial impact of ivabradine on reducing heart failure penalties under the Hospital Readmission Reduction Program.
1/2017	Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris.
9/2016	Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States.
2/2016	Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) Trial.
1/2016	Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT.
1/2016	Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT.
12/2015	Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).
12/2015	Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial.
10/2015	Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ian Ford Research Topics

Disease

65	Heart Failure 01/2022 - 12/2007
49	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 11/2002
43	Stroke (Strokes) 11/2021 - 05/2002
42	Coronary Disease (Coronary Heart Disease) 01/2021 - 05/2002
39	Myocardial Infarction 12/2021 - 05/2002
23	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2006
23	Hypertension (High Blood Pressure) 01/2020 - 11/2004
22	Systolic Heart Failure 12/2019 - 01/2010
19	Vascular Diseases (Vascular Disease) 03/2018 - 05/2002
18	Ischemic Stroke 01/2020 - 02/2009
15	Inflammation (Inflammations) 01/2021 - 06/2004
14	ST Elevation Myocardial Infarction 01/2021 - 08/2012
14	Left Ventricular Dysfunction 12/2015 - 02/2005
13	Type 2 Diabetes Mellitus (MODY) 10/2019 - 05/2002
11	Obesity 01/2021 - 10/2002
9	Infarction (Infarctions) 01/2019 - 02/2005
8	Atrial Fibrillation 01/2021 - 02/2005
7	Bradycardia 12/2015 - 01/2007
6	Hemorrhage 01/2021 - 01/2016
6	Atherosclerosis 01/2021 - 04/2010
6	Acute Coronary Syndrome 01/2021 - 11/2013
6	Diabetes Mellitus 01/2017 - 02/2009
6	Cognitive Dysfunction 01/2016 - 11/2007
5	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 02/2005
5	Hypothyroidism 01/2020 - 01/2017
5	Angina Pectoris 01/2019 - 01/2007
5	Weight Loss (Weight Reduction) 01/2019 - 05/2015
5	Insulin Resistance 10/2017 - 05/2012
5	Rheumatoid Arthritis 06/2017 - 06/2004
5	Transient Ischemic Attack 04/2016 - 02/2007
5	Heart Diseases (Heart Disease) 01/2016 - 05/2010
4	Thrombosis (Thrombus) 01/2021 - 03/2010
4	Gout 11/2020 - 07/2014
4	Ventricular Remodeling 01/2018 - 06/2009
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2016 - 07/2003
4	Neoplasms (Cancer) 12/2015 - 11/2002
4	Stable Angina 01/2011 - 12/2005
4	Hypercholesterolemia 10/2007 - 07/2003
3	Iron Deficiencies 08/2021 - 11/2013
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 01/2017
3	Infections 01/2020 - 01/2011
3	Death (Near-Death Experience) 01/2020 - 01/2019
3	Cardiomyopathies (Cardiomyopathy) 12/2019 - 10/2011
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019 - 01/2017
3	Body Weight (Weight, Body) 02/2017 - 01/2015
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 02/2013

Drug/Important Bio-Agent (IBA)

44	IvabradineIBA 12/2019 - 12/2005
40	Pravastatin (Pravachol)FDA LinkGeneric 12/2019 - 05/2002
31	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2018 - 10/2002
17	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2007
16	LipidsIBA 11/2018 - 10/2002
15	C-Reactive ProteinIBA 11/2021 - 07/2003
13	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 02/2014
13	LDL CholesterolIBA 11/2018 - 01/2006
12	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2008
12	Pharmaceutical PreparationsIBA 01/2020 - 02/2007
12	CholesterolIBA 01/2019 - 07/2003
10	oxidized low density lipoproteinIBA 11/2018 - 10/2002
9	Insulin (Novolin)FDA Link 01/2021 - 09/2012
8	IronIBA 12/2021 - 11/2013
8	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 12/2009
8	Interleukin-6 (Interleukin 6)IBA 01/2018 - 08/2004
8	HDL CholesterolIBA 10/2017 - 10/2002
6	Proteins (Proteins, Gene)FDA Link 10/2020 - 02/2012
6	terutrobanIBA 03/2019 - 04/2010
6	Biological ProductsIBA 01/2017 - 01/2007
6	DiureticsIBA 02/2016 - 05/2007
6	Triglycerides (Triacylglycerol)IBA 01/2016 - 04/2007
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 04/2010
5	Tenecteplase FDA Link 01/2020 - 04/2015
5	Lipoproteins (Lipoprotein)IBA 01/2018 - 11/2007
5	pro-brain natriuretic peptide (1-76)IBA 12/2017 - 02/2013
4	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 02/2014
4	Allopurinol (Remid)FDA LinkGeneric 11/2020 - 07/2014
4	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2020 - 01/2017
4	Thyroid HormonesIBA 01/2020 - 01/2017
4	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 01/2015
4	omega-Chloroacetophenone (Mace)IBA 01/2019 - 04/2016
4	AldosteroneIBA 01/2018 - 05/2007
4	ReninIBA 01/2018 - 05/2007
4	TroponinIBA 12/2017 - 09/2015
4	ApolipoproteinsIBA 01/2016 - 11/2007
4	LDL Lipoproteins (beta Lipoproteins)IBA 02/2012 - 09/2008
4	MelatoninIBA 01/2011 - 02/2005
3	Uric Acid (Urate)IBA 11/2020 - 07/2014
3	GadoliniumIBA 01/2019 - 08/2012
3	PCSK9 InhibitorsIBA 11/2018 - 01/2017
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2018 - 05/2007
3	Lipoprotein(a)IBA 01/2018 - 02/2012
3	HDL LipoproteinsIBA 10/2017 - 01/2009
3	P-2 (P 2)IBA 04/2017 - 01/2016

Therapy/Procedure

66	Therapeutics 11/2021 - 07/2003
14	Percutaneous Coronary Intervention 01/2021 - 08/2012
8	Cardiac Resynchronization Therapy 01/2018 - 09/2008
5	Secondary Prevention 01/2022 - 07/2003
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 01/2016
4	Stents 08/2019 - 05/2014
3	Renal Dialysis (Hemodialysis) 11/2021 - 01/2020
3	Bariatric Surgery 01/2021 - 05/2015
3	Drug Therapy (Chemotherapy) 01/2018 - 01/2014